ArticleOPEN ACCESS

Combination of EGFR and COX-2 inhibitors in breast cancer patient.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
DOI: 10.1007/s13277-012-0345-z
3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Ther combination of EGFR and COX-2 inhibitors in breast cancer patient treatment is a topic of interest. In this work, the author discusses on the synergistic effect of concomitant usage of the two drugs and also further notes on the myth in using this combination.

Cite

CITATION STYLE

APA

Wiwanitkit, V. (2012). Combination of EGFR and COX-2 inhibitors in breast cancer patient. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine. https://doi.org/10.1007/s13277-012-0345-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free